Back to Team Previously with: Matthew Cramblett Head of Clinical Operations Matthew has over 30 years of experience in clinical research and development with roles in academic research, biotech, and CRO services. He began his career in clinical research management,...
Back to Team Previously with: Carlos Paya, MD, PhD Head of R&D Carlos is the former CEO of Immune Design Corp., a late-stage Immunotherapy company which was acquired by Merck & Co. in April 2019. He previously served as President of Elan Pharmaceuticals and...
Back to Team Previously with: Michael Doherty Chief Regulatory Officer Michael was Head of Product Development at Foundation Medicine from the 2016 to 2019. In this role, he led a team dedicated to the introduction of clinical and data products in the field of cancer...
Back to Team Previously with: Shao-Chun Chang, MD, PhD Chief Medical Officer Shao is a seasoned pharmaceutical executive with more than 15 years of experience. Most recently, Shao was Senior Vice President, Head Of Clinical Development at BeiGene, where he led a...
Back to Team Previously with: Elisha Talley-Roithner Head of Operations Elisha has over 25 years of drug development experience. Elisha spent the last 14 years at PPD where she was most recently, Head of Development Operations. In this role, she had global...
